| 308 | 5 | 88 |
| 下载次数 | 被引频次 | 阅读次数 |
为评估发热伴血小板减少综合征病毒(Severe fever with thrombocytopenia syndrome virus, SFTSV)在环境中的稳定性，本研究比较分析了实验室制备的SFTSV在不同介质表面的稳定性以及温度、自然通风干燥和常用酒精消毒剂等因素对其生存能力的影响。不同时间点收获的病毒样本，通过接种于Vero细胞中传代培养、空斑试验和实时荧光定量RT-PCR等方法测定病毒的感染性、滴度和复制培养过程中的动态变化。结果显示，在室温(约25℃)自然通风干燥条件下，不同介质表面的SFTSV感染性快速下降，在硬币、塑料等介质表面的病毒感染性可维持24 h，但病毒感染性滴度24 h内显著下降分别约104.46倍和104.6倍，在无纺布和纸张表面的病毒感染性滴度在6 h内就下降分别约103.82倍和104.12倍。如果将SFTSV置于密闭湿润环境中，病毒感染性可维持长时间的稳定性，24 h病毒感染性滴度下降不明显，1周内下降约101.49倍，在3周时仍可通过细胞培养分离到感染性病毒颗粒，4周后失去了感染性；而SFTSV处于4℃时，感染性保持相对稳定性，在4周后，病毒感染性滴度下降仅约102.09倍，可通过细胞分离培养扩增病毒。使用酒精消毒剂对物体表面消毒时受SFTSV在物体表面的状态影响，当病毒处于干燥状态时，喷洒70%酒精可灭活病毒，如果处于湿润状态则不能有效灭活病毒。本研究比较研究了不同环境条件下SFTSV的稳定性，显示了环境材料性质、自然通风干燥程度、温度对SFTSV感染性的影响，有助于增进对SFTSV接触传播风险的理解，为完善SFTSV防控措施提供了参考依据。
Abstract：This study aimed to evaluate the stability of severe fever with thrombocytopenia syndrome virus(SFTSV) in the environment by comparing the viral stability on different surfaces and the effects of temperature, natural ventilation, and alcohol disinfectants on its survival. Virus samples collected at different time points were tested for infectivity, titer, and dynamic changes during replication by inoculating into Vero cells, plaque assay, and real-time fluorescence quantitative RT-PCR. Results showed that the infectivity of SFTSV on different surfaces rapidly decreased under natural ventilation and drying conditions at room temperature(about 25℃). The virus' s infectivity on surfaces such as coins and plastics could be maintained for 24 hours, but the infectivity titer decreased significantly by about 104.46 and 104.6 fold within 24 hours. The infectivity titer of the virus on Nonwoven cloth and paper surfaces decreased by about 103.82 and 104.12 fold, respectively, within 6 hours. If the SFTSV on the surface of the medium was placed in a closed and humid environment, the infectivity could be maintained for a long time. The infectivity titer decreased significantly by about 101.49 fold within 1 week, but infectious virus particles could still be isolated by cell culture after 3 weeks.After 4 weeks, the virus lost its infectivity. When SFTSV was at 4℃, the infectivity remained relatively stable.The infectivity titer decreased by only about 102.09 fold after 4 weeks, and the virus could be amplified by cell isolation and culture. The use of alcohol disinfectants on the surface of objects was affected by the state of SFTSV on the surface. When the virus was in a dry state, spraying 70% alcohol could inactivate the virus, but it could not effectively inactivate the virus in a wet state. This study compared the stability of SFTSV under different environmental conditions, showing the effects of environmental material properties, natural ventilation and drying degree, and temperature on the infectivity of SFTSV. It helps to understand the risk of SFTSV contact transmission and provides a reference for improving SFTSV prevention and control measures.
[1] Abudurexiti A, Adkins S, Alioto D, Alkhovsky S V,Avsic-Zupanc T, Ballinger M J, Bente D A, Beer M,Bergeron E, Blair C D, Briese T, Buchmeier M J, Burt F J, Calisher C H, Chang C, Charrel R N, Choi I R,Clegg J C S, De La Torre J C, De Lamballerie X,Deng F, Di Serio F, Digiaro M, Drebot M A, Duan X,Ebihara H, Elbeaino T, Ergunay K, Fulhorst C F,Garrison A R, Gao G F, Gonzalez J J, Groschup M H,Gunther S, Haenni A L, Hall R A, Hepojoki J,Hewson R, Hu Z, Hughes H R, Jonson M G, Junglen S, Klempa B, Klingstrom J, Kou C, Laenen L,Lambert A J, Langevin S A, Liu D, Lukashevich I S,Luo T, Lu C, Maes P, De Souza W M, Marklewitz M, Martelli G P, Matsuno K, Mielke-Ehret N,Minutolo M, Mirazimi A, Moming A, Muhlbach H P,Naidu R, Navarro B, Nunes M R T, Palacios G, Papa A, Pauvolid-Correa A, Paweska J T, Qiao J,Radoshitzky S R, Resende R O, Romanowski V, Sall A A, Salvato M S, Sasaya T, Shen S, Shi X, Shirako Y, Simmonds P, Sironi M, Song J W, Spengler J R,Stenglein M D, Su Z, Sun S, Tang S, Turina M,Wang B, Wang C, Wang H, Wang J, Wei T,Whitfield A E, Zerbini F M, Zhang J, Zhang L, Zhang Y, Zhang Y Z, Zhang Y, Zhou X, Zhu L, Kuhn J H.Taxonomy of the order Bunyavirales:update 2019[J/OL]. Arch Virol, 2019, 164(7):1949-1965. DOI:10.1007/s00705-019-04253-6.
[2] Yu X J, Liang M F, Zhang S Y, Liu Y, Li J D, Sun Y L, Zhang L, Zhang Q F, Popov V L, Li C, Qu J, Li Q, Zhang Y P, Hai R, Wu W, Wang Q, Zhan F X,Wang X J, Kan B, Wang S W, Wan K L, Jing H Q,Lu J X, Yin W W, Zhou H, Guan X H, Liu J F, Bi Z Q, Liu G H, Ren J, Wang H, Zhao Z, Song J D, He J R, Wan T, Zhang J S, Fu X P, Sun L N, Dong X P,Feng Z J, Yang W Z, Hong T, Zhang Y, Walker D H,Wang Y, Li D X. Fever with thrombocytopenia associated with a novel bunyavirus in China[J/OL]. N Engl J Med, 2011, 364(16):1523-1532. DOI:10.1056/NEJMoa1010095.
[3] Casel M A, Park S J, Choi Y K. Severe fever with thrombocytopenia syndrome virus:emerging novel phlebovirus and their control strategy[J/OL]. Exp Mol Med, 2021, 53(5):713-722. DOI:10.1038/s12276-021-00610-1.
[4] Tran X C, Yun Y, Van An L, Kim S H, Thao N T P,Man P K C, Yoo J R, Heo S T, Cho N H, Lee K H.Endemic Severe Fever with Thrombocytopenia Syndrome, Vietnam[J/OL]. Emerg Infect Dis, 2019,25(5):1029-1031. DOI:10.3201/eid2505.181463.
[5] Kim K H, Yi J, Kim G, Choi S J, Jun K I, Kim N H,Choe P G, Kim N J, Lee J K, Oh M D. Severe fever with thrombocytopenia syndrome, South Korea, 2012[J/OL]. Emerg Infect Dis, 2013, 19(11):1892-1894.DOI:10.3201/eid1911.130792.
[6] Takahashi T, Maeda K, Suzuki T, Ishido A, Shigeoka T, Tominaga T, Kamei T, Honda M, Ninomiya D,Sakai T, Senba T, Kaneyuki S, Sakaguchi S, Satoh A, Hosokawa T, Kawabe Y, Kurihara S, Izumikawa K, Kohno S, Azuma T, Suemori K, Yasukawa M,Mizutani T, Omatsu T, Katayama Y, Miyahara M,Ijuin M, Doi K, Okuda M, Umeki K, Saito T,Fukushima K, Nakajima K, Yoshikawa T, Tani H,Fukushi S, Fukuma A, Ogata M, Shimojima M,Nakajima N, Nagata N, Katano H, Fukumoto H, Sato Y, Hasegawa H, Yamagishi T, Oishi K, Kurane I,Morikawa S, Saijo M. The first identification and retrospective study of Severe Fever with Thrombocytopenia Syndrome in Japan[J/OL]. J Infect Dis, 2014, 209(6):816-827. DOI:10.1093/infdis/jit603.
[7] Boulanger N, Boyer P, Talagrand-Reboul E,Hansmann Y. Ticks and tick-borne diseases[J/OL].Med Mal Infect, 2019, 49(2):87-97. DOI:10.1016/j.medmal.2019.01.007.
[8] Rochlin I, Toledo A. Emerging tick-borne pathogens of public health importance:a mini-review[J/OL]. J Med Microbiol, 2020, 69(6):781-791. DOI:10.1099/jmm.0.001206.
[9] Hu Y Y, Zhuang L, Liu K, Sun Y, Dai K, Zhang X A, Zhang P H, Feng Z C, Li H, Liu W. Role of three tick species in the maintenance and transmission of Severe Fever with Thrombocytopenia Syndrome Virus[J/OL]. PLoS Negl Trop Dis, 2020, 14(6):e0008368. DOI:10.1371/journal.pntd.0008368.
[10]Yang Z D, Hu J G, Lu Q B, Guo C T, Cui N, Peng W, Wang L Y, Qin S L, Wang H Y, Zhang P H,Zhang X A, Liu W, Cao W C. The prospective evaluation of viral loads in patients with severe fever with thrombocytopenia syndrome[J/OL]. J Clin Virol,2016, 78:123-128. DOI:10.1016/j.jcv.2016.03.017.
[11]Jeong E J, Song J Y, Lim C S, Lee I, Park M S, Choi M J, Jeon J H, Kang S H, Jung B K, Yoon J G, Hyun H J, Noh J Y, Cheong H J, Kim W J. Viral shedding from diverse body fluids in a patient with severe fever with thrombocytopenia syndrome[J/OL]. J Clin Virol,2016, 80:33-35. DOI:10.1016/j.jcv.2016.04.018.
[12]Sharma D, Kamthania M. A new emerging pandemic of severe fever with thrombocytopenia syndrome(SFTS)[J/OL]. Virusdisease, 2021, 32(2):220-227. DOI:10.1007/s13337-021-00656-9.
[13]Li J, Li S, Yang L, Cao P, Lu J. Severe fever with thrombocytopenia syndrome virus:a highly lethal bunyavirus[J/OL]. Crit Rev Microbiol, 2021, 47(1):112-125. DOI:10.1080/1040841X.2020.1847037.
[14]Jung I Y, Choi W, Kim J, Wang E, Park S W, Lee W J, Choi J Y, Kim H Y, Uh Y, Kim Y K. Nosocomial person-to-person transmission of severe fever with thrombocytopenia syndrome[J/OL]. Clin Microbiol Infect, 2019, 25(5):633 e631-633 e634. DOI:10.1016/j.cmi.2019.01.006.
[15]Hu L, Li J, Zhang H, Bian T, Pan J, Li J, Xu X, Gao Y, Chen G, Ye Y, Li J. Predisposing factors for personto-person transmission of severe fever with thrombocytopenia syndrome bunyavirus[J/OL]. J Hosp Infect, 2022, 123:174-178. DOI:10.1016/j.jhin.2021.10.023.
[16]张全福，李建东，姜晓林，李川，刘林，梁米芳，李德新.发热伴血小板减少综合征病毒热稳定性和灭活条件初步研究[J/OL].中华实验和临床病毒学杂志，2014,(03):206-208. DOI:10.3760/cma. j. issn. 1003-9279.2014.03.016.
[17]Chin A W H, Poon L L M. Stability of SARS-CoV-2 in different environmental conditions-Authors'reply[J/OL]. Lancet Microbe, 2020, 1(4):e146. DOI:10.1016/S2666-5247(20)30095-1.
[18]Van Doremalen N, Bushmaker T, Morris D H,Holbrook M G, Gamble A, Williamson B N, Tamin A, Harcourt J L, Thornburg N J, Gerber S I, LloydSmith J O, De Wit E, Munster V J. Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1[J/OL]. N Engl J Med, 2020, 382(16):1564-1567. DOI:10.1056/NEJMc2004973.
[19]韦雪敏，李书晗，王耀，陈梦婷，赵丽，王志玉，万敏，温红玲.发热伴血小板减少综合征病毒温度敏感性研究[J].中国人兽共患病学报，2022,(01):25-28
[20]甘芳容，张烨，谭敏菊，成艳辉，薄洪，房琼琼，周为民，王大燕，董婕，武桂珍.理化条件对人感染H9N2禽流感病毒灭活效果的评价[J/OL].中华实验和临床病毒学杂志，2020,(01):87-88-89-90-91. DOI:10.3760/cma.j.issn.1003-9279.2020.01.018.
[21]李婕，严冬梅，张勇，许文波，祝双利，周为民，武桂珍.肠道病毒A组71型热力和常见3种化学消毒剂灭活效果的研究[J/OL].中华实验和临床病毒学杂志，2020,(01):18-19-20-21-22. DOI:10.3760/cma. j.issn.1003-9279.2020.01.004.
基本信息:
DOI：10.13242/j.cnki.bingduxuebao.004391
中图分类号:R373
引用信息:
[1]杨晓艺,杜珊珊,黄晓霞等.发热伴血小板减少综合征病毒在不同环境条件下的稳定性研究[J].病毒学报,2023,39(06):1521-1527.DOI:10.13242/j.cnki.bingduxuebao.004391.
基金信息: